关于大脑衰老的生物标志物的框架:衰老生物标志物联盟的一致声明
, Yu-Juan Jia1,2, Jun Wang1
1Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Life medicine
|January 28, 2025
概括
全球人口老龄化需要有效的脑衰老评估. 专家们就大脑衰老生物标志物达成共识,以指导干预措施,并改善全球老年人的大脑健康.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 生物标志物发现发现
背景情况:
- 全球人口面临着严重的老龄化挑战,与年龄相关的疾病的流行率正在增加.
- 大脑衰老是主要神经系统疾病 (如神经退行性疾病和中风) 的关键因素.
- 对大脑衰老的有效评估对于开发干预措施和治疗方法至关重要.
研究的目的:
- 推验证的生物标志物来评估大脑衰老.
- 建立关于大脑衰老评估的专家共识.
- 为研究提供基础,改善老年人的全球大脑健康.
主要方法:
- 老龄化生物标志物联盟 (ABC) 专家的共识发展.
- 整合最新的研究成果和实际的临床经验.
- 识别和推特定的大脑衰老生物标志物.
主要成果:
- 关于推的大脑衰老生物标志物的共识已经建立.
- 提出了一个评估大脑衰老程度的框架.
- 这些建议旨在支持有针对性的研究和临床应用.
结论:
- 专家的共识为评估大脑衰老提供了基础.
- 这一举措对于推进打击与年龄相关的大脑疾病的战略至关重要.
- 最终目标是提高全球老龄人口的大脑健康.
更多相关视频
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.6K
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.8K
相关概念视频
01:26Aging
36
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
36
01:26Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439